TGA
RACGP renews S4 paracetamol push
Proposed changes to paracetamol pack sizes are “unlikely to significantly impact the harms from overdose”, the Royal Australian College of General Practitioners (RACGP) warns While welcoming the Therapeutic Goods Administration’s …
Complementary medicines manufacturer cops $160k fine
Breaches of Good Manufacturing Practices (GMP) are proving costly for complementary medicines firm, Contract Manufacturing and Packaging Services Pty Ltd The Sydney-based business has been handed 12 infringement notices totalling …
Warfarin products go into shortage
The TGA is urging pharmacists and consumers not to stockpile Coumadin or Marevan, as part of a shortage warning The TGA has announced that several warfarin products are in shortage …
Ozempic scams abound, TGA warns
As shortage eases, regulator tells consumers to only deal with Australian pharmacies when buying the medicine The Therapeutic Goods Administration (TGA) has warned consumers to only obtain the shortage-plagued diabetes …
Pholcodine cancelled, recalled
The TGA is recalling 55 products containing pholcodine from pharmacy shelves – and cancelling them from the ARTG The Therapeutic Goods Administration conducted a safety investigation into the pholcodine products, …
Provisional approval for adolescent bivalent booster
Moderna’s bivalent Covid-19 vaccine (elasomeran and davesomeran) has been granted provisional approval for use as a booster in adolescents aged 12 years and older The vaccine is the second targeting …
Skerritt estimates hearing suspended five times
Outgoing Therapeutic Goods Administration (TGA) boss, Professor John Skerritt, endured an interrupted appearance at Senate Estimates yesterday The hearing was suspended five times in the space of an hour, as …
Ozempic about to hit shelves… but there’s a catch
The TGA has announced that supplies of Ozempic (semaglutide) have begun being distributed—but pharmacies will have to be subject to purchasing limits Following skyrocketing demand for Ozempic due at least …
Avoid pregabalin during pregnancy: TGA
“Risk of major congenital malformations” prescribers warned as drug moved to pregnancy Category D The Therapeutic Goods Administration (TGA) has strengthened its warnings around epilepsy and pain drug pregabalin for …
‘Our members understand the impacts of paracetamol poisoning.’
Pharmacists working in hospital have a real understanding of the consequences of paracetamol poisoning, says the SHPA Last month (3 February), the Therapeutic Goods Administration announced its interim decision to …
Keeping to the schedule
Scheduling decisions for ibuprofen, S3 melatonin, S3 fexofenadine and S2 brimonidine announced Decisions around the scheduling of a range of medicines have been announced with the release of interim decisions …
What now for psychedelics?
Following the TGA’s decision to reschedule MDMA and psilocybin to S8 for certain specific conditions, what will change for pharmacists? The recent TGA decision means that the two psychedelic substances …